Table 2.
Treatment | IC50 a (concentration ± S.E.M.) | Maximum effect (% ± S.E.M.) |
---|---|---|
Pentamidine | 0.9 ± 0.03 µM/0.3 ± 0.01 µg/mL | 93.5 ± 0.7** |
EtOH extract | 0.7 ± 0.1 µg/mL | 91.6 ± 2.5** |
MeOH : H2O fraction | 3.9 ± 1.5 µg/mL | 61.5 ± 1.2** |
AcOEt fraction | 0.4 ± 0.1 µg/mL | 81.5 ± 5.9** |
Hexane fraction | 0.2 ± 0.1 µg/mL | 90.0 ± 3.6** |
1 | 6.9 ± 0.7 µM/2.5 ± 0.04 µg/mL | 56.0 ± 0.8** |
2 | >100 µM/>36.0 µg/mL | 48.8 ± 1.7** |
3 | >100 µM/>36.0 µg/mL | NA |
4 | 5.4 ± 0.8 µM/2.0 ± 0.3 µg/mL | 69.1 ± 2.7** |
5 | >100 µM/>20.8 µg/mL | NA |
7 | >100 µM/>31.4 µg/mL | NA |
Data are reported as the mean ± S.E.M. Differences with a *P value < 0.05 were considered significant relative to the 0.1% DMSO group.
aIC50 is the concentration required to give 50% mortality, calculated by linear regression analysis from the Kc values at the concentrations employed.
NA: the compound is not active.